RxDoctor Payments Data

Jeannine Hughes, MD

Family Medicine · Westerville, OHNPI 1457320434

Payments from drug & device makers

$18,852in general payments, 2019–2025

Across 1,344 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Pfizer$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • GSK$1K
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$18,795100%
  • Education$570%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)216$2,700
AstraZeneca(2 entities)80$1,718
Pfizer119$1,581
Novo Nordisk118$1,536
Lilly USA, LLC96$1,263
GSK82$1,145
Johnson & Johnson76$1,052
Boehringer Ingelheim72$859
Amgen(2 entities)48$603
Bayer32$573
Takeda Pharmaceuticals U.S.A., Inc.36$540
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC40$476
Merck41$443
Amarin Pharma, Inc.34$419
Abbott19$338
Axsome Therapeutics, Inc.14$311
Sanofi-aventis U.S. LLC26$283
Exact Sciences12$269
Astellas Pharma US Inc13$266
Biohaven Pharmaceuticals, Inc.22$201
E.r. Squibb & Sons, L.L.C.11$176
Biohaven Pharmaceutical Holding Company Ltd.14$153
Teva Pharmaceuticals USA, Inc.10$138
Sumitomo Pharma America, Inc.8$130
Novartis8$117
QOL Medical, LLC4$114
Eisai Inc.7$104
Kowa Pharmaceuticals America, Inc.7$87
Xeris Pharmaceuticals, Inc.5$84
Neos Therapeutics, LP5$78
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$72
Sanofi Pasteur Inc.4$71
IBSA Pharma Inc.4$67
Otsuka America Pharmaceutical, Inc.4$67
Phathom Pharmaceuticals, Inc.4$64
Bausch Health US, LLC4$54
Supernus Pharmaceuticals, Inc.4$52
Lundbeck LLC3$51
Sunovion Pharmaceuticals Inc.3$51
Clarus Therapeutics Inc.5$50
Arbor Pharmaceuticals, Inc.2$38
Amneal Pharmaceuticals LLC2$37
Dexcom, Inc.2$37
Genentech USA, Inc.2$35
Medtronic1$26
Endo Pharmaceuticals Inc.2$26
Shire North American Group Inc2$23
Actelion Pharmaceuticals US, Inc.1$21
Jazz Pharmaceuticals Inc.1$21
Nestle Healthcare Nutrition Inc.1$20
Evoke Pharma, Inc.1$18
Inari Medical, Inc.1$18
Corcept Therapeutics1$17
Lucid Diagnostics Inc.1$16
Biogen1$15
Shield Therapeutics Inc1$15
Vertical Pharmaceuticals, LLC1$15
Noven Therapeutics, LLC1$14
Grifols USA, LLC1$13
Esperion Therapeutics, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,852 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$98,207
Medicare patients
280
Services billed
2,518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$59,623
JardianceEmpagliflozin41$45,956
XareltoRivaroxaban50$40,312
FarxigaDapagliflozin Propanediol30$32,162
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$28,533
Breztri AerosphereBudesonide/Glycopyr/Formoterol47$28,158
OzempicSemaglutide23$22,859
TrulicityDulaglutide15$22,052
MounjaroTirzepatide16$21,856
ProliaDenosumab12$20,692
JanumetSitagliptin Phos/Metformin Hcl12$19,149
JanuviaSitagliptin Phosphate16$18,981
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$15,025
Breo ElliptaFluticasone/Vilanterol19$10,608
Tresiba Flextouch U-100Insulin Degludec11$8,428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,718$60,32077 claims
PfizerEliquis$1,581$59,62364 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$1,145$54,16676 claims
Boehringer IngelheimJardiance$859$45,95641 claims
Lilly USA, LLCTrulicity, Mounjaro$1,263$43,90931 claims
Johnson & JohnsonXarelto$1,052$40,31250 claims
MerckJanumet, Januvia$443$38,12928 claims
Novo NordiskOzempic$1,536$22,85923 claims
AmgenProlia$603$20,69212 claims
AbbVieSynthroid$2,700$2,76149 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$37$1,715255 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →